ClinicalTrials.govpublic full text
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
acromegaly, somatostatin analogs, somatuline® autogel®, lanreotide, growth hormone, igf-1, inappropriate growth hormone secretion syndrome, somatotropin hypersecretion syndrome, inappropriate gh secretion syndrome, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842225
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.